PTC Therapeutics Total Current Liabilities

PTC Therapeutics (PTCT) currently reports a total current liabilities of $920M as of March 2026. That compares with $600M in the prior-year period — up 55.1% year over year. Use the charts on this page to explore PTC Therapeutics's total current liabilities history and peer comparisons.

PTC Therapeutics's total current liabilities increased from $600M to $920M — a 55.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PTC Therapeutics reported $920M in total current liabilities as of March 2026. That compares with $600M in the prior-year period — up 55.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $920M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for PTC Therapeutics, and consider following PTCT for alerts when major investors trade the stock.

PTC Therapeutics is classified in the Healthcare sector. On total current liabilities, it currently shows $920M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PTCT with unrelated industries.